"We are aware a small number of our employees in China are under investigation and we have no further information to share at this point," ...

On Wednesday, U.S. District Judge Matthew Kennelly invalidated Pfizer’s patents related to the cancer drug Nerlynx, overturning a jury's $1...

The Anglo-Swedish drugmaker announced the schedule as it released second-quarter financial results, which showed that the company and its s...

The advice for healthcare professionals was provided by the European Medicines Agency (EMA) as part of an ongoing review into rare, but sev...

On April 15, the Norwegian Institute of Public Health said the AstraZeneca vaccine should be dropped entirely but the government sought fur...

"AstraZeneca has fully complied with the Advance Purchase Agreement with the European Commission and will strongly defend itself in court. ...

The European Union member states and the pharmaceutical company are at odds over the delivery of the shots after the group shipped to the b...

Confidence in the AstraZeneca vaccine has dropped in Europe since a very few, mostly young, recipients of the shot were found to have suffe...

The decision came after the country's medical regulator announced that it had received a total of 31 reports of rare blood clots in recent ...

Manitoba and Quebec provinces were the first to heed the new National Advisory Committee on Immunization and Health (NACI) guidelines, with...

British Prime Minister Boris Johnson said on Wednesday he would get the Oxford/AstraZeneca COVID-19 shot very soon, voicing his confidence ...

Canadian health experts are sure all COVID-19 vaccines being administered in the country are safe, including those made by AstraZeneca PLC,...

"India is a part of 'COVAX'. We will keep giving 50 per cent of everything we make to India and to COVAX at the same time. India has such a...

"These figures ... shows that the vaccine in the right dosage can be up to 90% effective," British Health Secretary Matt Hancock told Sky N...

AstraZeneca began its Phase 3 trial in the US in late August. The US trial was currently taking place at 62 sites across the country.

DRL’s generic version was to be marketed as Ticaflo, according to those in the know.

AstraZeneca have broken out of the narrow trading range in June, driven by two positive news flows. The stock has rallied 37.41% since June...